Solara Active Pharma Sciences Ltd - ESG Rating & Company Profile powered by AI
Scroll down to the bottom of this webpage for potential risks for Solara Active Pharma Sciences Ltd based on sector, geography and size. If you work at Solara Active Pharma Sciences Ltd and you wish to licence your ESG aseessment, please get in touch. Full Sustainability assessment of Solara Active Pharma Sciences Ltd are reached by signing up for free.
Solara Active Pharma Sciences Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.8; made up of an environmental score of 2.0, social score of 3.2 and governance score of 3.2.
2.8
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1353 | Vera Therapeutics Inc | 2.9 | Medium |
1353 | Veracyte Inc | 2.9 | Medium |
1393 | Solara Active Pharma Sciences Ltd | 2.8 | Medium |
1393 | Bioventix PLC | 2.8 | Medium |
1393 | Bolt Biotherapeutics Inc | 2.8 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Solara Active Pharma Sciences Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Solara Active Pharma Sciences Ltd disclose current and historical energy intensity?
Does Solara Active Pharma Sciences Ltd report the average age of the workforce?
Does Solara Active Pharma Sciences Ltd reference operational or capital allocation in relation to climate change?
Does Solara Active Pharma Sciences Ltd disclose its ethnicity pay gap?
Does Solara Active Pharma Sciences Ltd disclose cybersecurity risks?
Does Solara Active Pharma Sciences Ltd offer flexible work?
Does Solara Active Pharma Sciences Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Solara Active Pharma Sciences Ltd disclose the number of employees in R&D functions?
Does Solara Active Pharma Sciences Ltd conduct supply chain audits?
Does Solara Active Pharma Sciences Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Solara Active Pharma Sciences Ltd conduct 360 degree staff reviews?
Does Solara Active Pharma Sciences Ltd disclose the individual responsible for D&I?
Does Solara Active Pharma Sciences Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Solara Active Pharma Sciences Ltd disclose current and / or historical scope 2 emissions?
Does Solara Active Pharma Sciences Ltd disclose water use targets?
Does Solara Active Pharma Sciences Ltd have careers partnerships with academic institutions?
Did Solara Active Pharma Sciences Ltd have a product recall in the last two years?
Does Solara Active Pharma Sciences Ltd disclose incidents of discrimination?
Does Solara Active Pharma Sciences Ltd allow for Work Councils/Collective Agreements to be formed?
Has Solara Active Pharma Sciences Ltd issued a profit warning in the past 24 months?
Does Solara Active Pharma Sciences Ltd disclose parental leave metrics?
Does Solara Active Pharma Sciences Ltd disclose climate scenario or pathway analysis?
Does Solara Active Pharma Sciences Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Solara Active Pharma Sciences Ltd disclose the pay ratio of women to men?
Does Solara Active Pharma Sciences Ltd support suppliers with sustainability related research and development?
Does Solara Active Pharma Sciences Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Solara Active Pharma Sciences Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Solara Active Pharma Sciences Ltd involved in embryonic stem cell research?
Does Solara Active Pharma Sciences Ltd disclose GHG and Air Emissions intensity?
Does Solara Active Pharma Sciences Ltd disclose its waste policy?
Does Solara Active Pharma Sciences Ltd report according to TCFD requirements?
Does Solara Active Pharma Sciences Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Solara Active Pharma Sciences Ltd disclose energy use targets?
Does Solara Active Pharma Sciences Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Solara Active Pharma Sciences Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Solara Active Pharma Sciences Ltd
These potential risks are based on the size, segment and geographies of the company.
Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India. The company offers APIs for anesthetics, anthelmintic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-viral, antibiotic, anticoagulant, anticonvulsant, antidepressant, antiemetic, antiepileptic, antifungal, antigout agent, antihistamine, antihyperlipoproteinemic, antimalarial, antimycotic, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antitussive, antiulcerative, anxiolytic, bile acid analogue, calcimimetic agent, cardiovascular agent, central nervous system agent, chronic alcoholism, chronic kidney disease, dopamine receptor antagonist, folate analog, hyperkalaemia, immunosuppressant, lipid regulating agent, loop diuretic, muscarinic agonist, neuromuscular, OAB treatment, phenylalanine reducer, recovery of stroke, tardive dyskinesia, treatment of glaucoma and hyperphosphatemia, tropical anti-infective, and type-II diabetes therapeutic categories. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical services, impurity synthesis, and regulatory support. In addition, the company exports its products. It operates in the Asia Pacific, Europe, North America, South America, and internationally. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.